The use of convalescent plasma to treat hospitalised and critically ill patients with COVID-19 disease

Registered study from NIHR funded awards. Evidence status: source reported.

Organisation

University of Oxford

Published

2020-05-01

Source reference

COVID-19-RECPLAS

Jurisdiction

United Kingdom (funder)

Licence

Open Government Licence v3.0. Contains public sector information from the NIHR Open Data portal; award holders' names not imported.

Contracted organisation: University of Oxford · Programme: NIHR Ad Hoc Contracts · Award: £3,127,919 · 2020-05-01 to 2024-04-30 · Status: Complete · Found via: a paper's funding metadata

Source: https://fundingawards.nihr.ac.uk/award/COVID-19-RECPLAS. Captured 2026-10-29.

Limitations: An NIHR funding award named, by its award number, in a held paper's funding metadata. The award funded research; it does not show which data the research used.